Are the best available clinical effectiveness data used in economic evaluations of drug therapies?

Journal of Health Services Research and Policy

Volumn 12, Issue 3, 2007, Pages 138-141

  Hanratty, Barbara ^a   Craig, Dawn ^b   Nixon, John ^b   Rice, Stephen ^b   Christie, James ^b   Drummond, Michael ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; DATA ANALYSIS; DATA BASE; DRUG EFFICACY; ECONOMIC EVALUATION; EVIDENCE BASED PRACTICE; PRIORITY JOURNAL; QUALITY CONTROL;

COST-BENEFIT ANALYSIS; DATABASES, BIBLIOGRAPHIC; DRUG THERAPY; ECONOMICS, PHARMACEUTICAL; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; REVIEW LITERATURE AS TOPIC; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 34547156166     PISSN: 13558196     EISSN: None     Source Type: Journal    
DOI: 10.1258/135581907781543067     Document Type: Article

References (27)

1. Minshall ME, Kody MC, Mosbacher F. Pharmacoeconomics research credibility: a controversial and recurring theme in health outcomes research. Med Care 1999;37 (Suppl Lilly): AS12-9
2. Coyle D, Lee KM. Evidenced-based economic evaluation: how the use of different data sources can impact results. In: Donaldson C, Mugford M, Vale L, eds. Evidenced-based Health Economics. London: BMJ Books, 2002;55-66
3. Drummond M, Cooke J, Walley T. Economic evaluation in health care decision-making: evidence from the UK. York: University of York, 1996
4. Gerard K. Cost-utility in practice: a policy maker's guide to the state of the art. Health Policy 1992;21:249-79
5. Udvarhelyi S, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature. Ann Intern Med 1992;116:238-44
6. Freemantle N, Maynard A. Something rotten in the state of clinical and economic evaluations? Health Econ 1994;3:305-7
7. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA 2002;287:2809-12
8. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005;43(Suppl):5-14
9. Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care 1996;12:209-37
10. Friedberg M, Saffran B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 1999;282:1453-7
11. Rennie D, Luft HS. Pharmacoeconomic analyses: making them transparent, making them credible. JAMA 2000;283: 2158-2160
12. Hill SR, Mitchell AS, Henry DA. Problems with the interpretation of pharmacoeconomic analyses. JAMA 2000; 283:2116-21
13. Miners AH, Gargau M, Fidan D, Fischer AJ. Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study. BMJ 2005;330:65
14. Hoffmann C, Stoykova BA, Nixon J, Glanville JM, Misso K, Drummond MF. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health 2002;5:65-6
15. Kernick DP. Has health economics lost its way? BMJ 1998;317:197-9
16. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994;164:665-73
17. Jonsson B. Economic evaluation and clinical uncertainty: response to Freemantle and Maynard. Health Econ 1994;3:305-7
18. NHS Economic Evaluation Database (NHS EED) available at http://www.york.ac.uk/inst/crd/nhsdhp.htm (accessed March 2006)
19. NHS Executive. Promoting Clinical Effectiveness: a Framework for Action in and Through the NHS. Leeds, Department of Health, 1996
20. Centre for Reviews & Dissemination. Improving Access to Cost-effectiveness Information for Health Care Decision Making: the NHS Economic Evaluation Database CRD Report Number 6. 2nd edn. York: University of York, 2001
21. Nixon J, Stoykova B, Christie J, Glanville J, Kleijnen J, Drummond M. NHS Economic Evaluation Database for healthcare decision makers. BMJ 2000;321:32
22. Database of Abstracts of Reviews of Effects, available http://www.york.ac.uk/inst/crd/crddatabases.htm (accessed March 2006)
23. Health Technology Assessment (HTA) Database available at http://www.york.ac.uk/inst/crd/htahp.htm (accessed March 2006)
24. The Cochrane Database of Systematic Reviews available in the UK http://www.mrw.interscience.wiley.com/cochrane/cochrane_clsysrev_articles_fs. html (accessed March 2006)
25. Stoykova B, Drummond MF, Barbieri M, Kliejnen J. The lag between effectiveness and cost-effectiveness evidence of new drugs: implications for decision making in health care. Eur J Health Econ 2003;4:313-8
26. Olsen O, Middleton P, Ezzo J, et al. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001;323: 829-32
27. Demicheli V, Jefferson T, Vale L. Effectiveness estimates in economic evaluation. In: Donaldson C, Mugford M, Vale L, eds. Evidence-based Health Economics. London: BMJ Books, 2002:89-98